Journal article
Long-term interferon-β treatment for multiple sclerosis
Abstract
Abstract.The aim of our study was to analyze the dropout rate in
patients with relapsing-remitting multiple sclerosis (RRMS)
Authors
Ruggieri RM; Settipani N; Viviano L; Attanasio M; Giglia L; Almasio P; La Bella V; Piccoli F
Journal
Neurological Sciences, Vol. 24, No. 5, pp. 361–364
Publisher
Springer Nature
Publication Date
December 2003
DOI
10.1007/s10072-003-0190-3
ISSN
1590-1874
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultDisability EvaluationDose-Response Relationship, DrugDrug Administration RoutesDrug Administration ScheduleFemaleHumansInterferon beta-1aInterferon beta-1bInterferon-betaMaleMiddle AgedMultiple Sclerosis, Relapsing-RemittingPatient CompliancePatient DropoutsSurvival AnalysisTimeTreatment Outcome